The adiponectin‐derived peptide ALY688 protects against the development of metabolic dysfunction‐associated steatohepatitis

• Ngā kaituhi matua: Zhe Huang (Author), Hye Kyoung Sung (Author), Xingqun Yan (Author), Shiyu He (Author), Leigang Jin (Author), Qin Wang (Author), Xuerui Wu (Author), Henry H. Hsu (Author), Angelica Pignalosa (Author), Kathryn Crawford (Author), Gary Sweeney (Author), Aimin Xu (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2024-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Metabolic dysfunction‐associated steatohepatitis (MASH) is the severe form of non‐alcoholic fatty liver disease which has a high potential to progress to cirrhosis and hepatocellular carcinoma, yet adequate effective therapies are lacking. Hypoadiponectinemia is causally involved in the pat...